Cratageus Oxyacantha
Also known as: Crataegus monogyna, Hawthorn, Crataegus oxyacantha
Overview
Crataegus oxyacantha, commonly known as hawthorn, is a botanical supplement derived from the berries and leaves of the hawthorn plant. It is primarily utilized for its potential benefits in cardiovascular health, including mild to moderate heart failure and hypertension. Hawthorn extracts are believed to exert cardiotonic, hypotensive, and lipid-lowering effects. Research on hawthorn is relatively mature, with several randomized controlled trials and meta-analyses supporting its use. While the quality of evidence is moderate, systematic reviews indicate some cardiovascular benefits, though further rigorous trials are needed to confirm optimal dosing and long-term safety. It is typically used as an adjunctive therapy rather than a replacement for conventional medications.
Benefits
Hawthorn extracts have demonstrated several evidence-based benefits, primarily in cardiovascular health. A meta-analysis indicates that *Crataegus* species significantly reduce systolic blood pressure compared to placebo, although effects on diastolic pressure are less consistent. For patients with mild to moderate heart failure (NYHA class II), hawthorn may improve exercise tolerance and reduce symptoms, with some trials showing borderline statistically significant improvements in cardiac function parameters. Additional reported effects include lipid-lowering, antioxidant, anxiolytic, hypoglycemic, and anti-inflammatory properties, though these are less extensively studied in clinical trials. Benefits are typically observed within 8 to 12 weeks of consistent use. The evidence mainly supports its use as an adjunctive therapy in patients with mild to moderate heart failure and hypertension.
How it works
Hawthorn extracts exert their cardiovascular effects through multiple mechanisms. They are believed to induce vasodilation, likely by modulating endothelial function and nitric oxide pathways, and by acting as calcium channel blockers. The cardioprotective effects may involve improved myocardial contractility and reduced peripheral resistance, leading to better heart function. At a molecular level, hawthorn's active constituents, primarily flavonoids and oligomeric procyanidins, interact with ion channels and enzymes involved in oxidative stress and inflammation. These compounds contribute to its antioxidant activity and overall beneficial impact on the cardiovascular system. Bioavailability of these active compounds can vary depending on the extract's standardization.
Side effects
Hawthorn extracts are generally well tolerated and have a favorable safety profile in clinical trials. Common side effects, reported in over 5% of users, include mild gastrointestinal discomfort. Less common side effects, occurring in 1-5% of users, include headache and dizziness. Serious adverse events are rare and have not been consistently reported. However, caution is advised due to potential interactions with conventional cardiovascular medications, such as digoxin and beta-blockers, as hawthorn may have additive effects. Contraindications include pregnancy and lactation due to limited data, and it should be used with caution in patients on multiple cardiac medications. While elderly patients with heart failure have been studied without major safety concerns, data in children and pregnant women are limited. Mild genotoxicity has been observed in cell and animal models, suggesting caution with very high doses.
Dosage
The optimal dosage for hawthorn extract is not definitively established and varies by the specific extract used. Clinical trials commonly employ standardized extracts equivalent to 160–180 mg of flavonoids daily, or 3 x 30 drops of a liquid extract. Doses in studies have ranged from 160 mg to 900 mg of extract daily. There is no clear maximum safe dose, and long-term safety at very high doses has not been extensively studied. Hawthorn is typically administered in divided doses, often with meals, to potentially enhance bioavailability. The quality and concentration of the extract are critical, with standardized forms like WS 1442 being commonly used in research. No specific cofactors are required for its efficacy.
FAQs
Is hawthorn safe for long-term use?
Current evidence supports the safety of hawthorn for short to medium-term use. However, its long-term effects, especially at higher doses, require further comprehensive study to confirm sustained safety.
Can hawthorn replace conventional heart failure medications?
No, hawthorn is considered an adjunctive therapy and should not replace prescribed conventional heart failure medications. It is intended to complement, not substitute, standard medical treatment.
When are benefits expected from hawthorn?
Improvements in cardiovascular parameters and symptoms are typically observed within 8 to 12 weeks of consistent daily use of hawthorn extract, as indicated by clinical trials.
Does hawthorn interact with blood pressure medications?
Yes, hawthorn has potential additive hypotensive effects when taken with blood pressure medications. It is crucial to monitor blood pressure closely and consult a healthcare professional to avoid excessive blood pressure drops.
Research Sources
- https://pmc.ncbi.nlm.nih.gov/articles/PMC12298042/ – This meta-analysis of randomized placebo-controlled trials demonstrated a significant reduction in systolic blood pressure with *Crataegus* spp. extracts. The study included multiple RCTs, used a random-effects model, and reported statistically significant effects, though it noted heterogeneity among studies and called for larger trials.
- https://www.frontiersin.org/journals/pharmacology/articles/10.3389/fphar.2020.00118/full – This comprehensive review summarized the cardioprotective, lipid-lowering, antioxidant, and other pharmacological effects of *C. oxyacantha*. It cited various clinical trials and mechanistic studies, also noting mild genotoxicity in cell and animal models, suggesting caution with high doses.
- https://pmc.ncbi.nlm.nih.gov/articles/PMC3891531/ – This placebo-controlled, double-blind randomized controlled trial involving 143 patients with NYHA class II heart failure showed improvements in heart failure parameters and exercise tolerance after 8 weeks of standardized hawthorn extract treatment. The improvements were statistically borderline but indicated safety and good tolerability.
- https://link.springer.com/article/10.1186/s40199-015-0137-2 – This randomized controlled trial compared *C. oxyacantha* extract and aerobic exercise in patients with stable angina, revealing anti-inflammatory effects. Despite a small sample size and some limitations in control groups, the study supports potential adjunctive benefits of hawthorn in this population.
